HCmed Innovations Co., Ltd. (TPEX:6934)
Taiwan · Delayed Price · Currency is TWD 148.50
+15.00 (11.24%)
At close: Jan 20, 2026
HCmed Innovations Revenue
HCmed Innovations had revenue of 10.86M TWD in the half year ending June 30, 2025, with 329.22% growth. This brings the company's revenue in the last twelve months to 122.94M, up 209.09% year-over-year. In the year 2024, HCmed Innovations had annual revenue of 141.61M with 1,433.43% growth.
Revenue (ttm)
122.94M
Revenue Growth
+209.09%
P/S Ratio
39.39
Revenue / Employee
n/a
Employees
n/a
Market Cap
4.84B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 141.61M | 132.38M | 1,433.43% |
| Dec 31, 2023 | 9.24M | 2.76M | 42.56% |
| Dec 31, 2022 | 6.48M | -47.58M | -88.02% |
| Dec 31, 2021 | 54.06M | 21.73M | 67.23% |
| Dec 31, 2020 | 32.32M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Hi-Clearance | 4.19B |
| Wellell | 2.39B |
| InnoCare Optoelectronics | 2.18B |
| Dynamic Medical Technologies | 1.43B |
| WeLeader Biomedical | 1.06B |
| A Plus Biotechnology | 825.52M |
| Delta Asia International | 711.19M |
| Diamond Biotechnology | 698.11M |